MDB Capital Group LLC
ProventionBio | $64 Million | Intial Public Offering | July 2018
Cue Biopharma, Inc. | $66 Million | Intial Public Offering | Jan 2018
Pulse Biosciences | $23 Million | Initial Public Offering | June 2016
Second Sight | $36 Million | Initial Public Offering | November 2014
Energous Corporation | $27.6 Million | Initial Public Offering | March 2014
MDB Capital Group finances development stage companies that possess meaningful technology that has the potential to impact large commercial markets and benefit humanity. MDB maximizes the value of these technology companies by helping position them to be the dominant leader in their technology domain and connecting them with a base of high-quality investors.